戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ongation factor alpha1) and eEF2 (eukaryotic elongation factor 2).
2  sleep-related gene encoding the translation elongation factor 2.
3  protein synthesis caused by inactivation of elongation factor 2.
4 ptide is identical to residues 581 to 589 of elongation factor 2.
5 nslocates to the cytosol and ADP-ribosylates elongation factor 2.
6 ocates into the cytosol where it inactivates elongation factor 2.
7 ot(ID)-predicted PPI-hot spots of eukaryotic elongation factor 2.
8  synthesis by ADP-ribosylation of eukaryotic elongation factor 2.
9 ible for the trimethylation of lysine 509 on elongation factor 2.
10 re toxin to reach the cytosol and inactivate elongation factor 2.
11 bosyltransferase activity against eukaryotic elongation factor 2.
12 found in archaeal and eukaryotic translation elongation factor 2.
13 single amino acid substitution in eukaryotic elongation factor 2.
14  inhibition at the fungal protein eukaryotic elongation factor 2.
15 NAD-dependent ADP-ribosylation of eukaryotic elongation factor 2.
16 ding of the C domain of DT to its substrate, elongation factor-2.
17 cells via ADP-ribosylation of the eukaryotic elongation factor-2.
18 inase in turn phosphorylates and inactivates elongation factor-2, a key mediator of ribosomal transfe
19 tresses on the phosphorylation of eukaryotic elongation factor 2 also differed: oxidative stress elic
20 reduced phosphorylation levels of eukaryotic elongation factor 2 and also requires the presence of el
21 ed diphtheria toxin (DT), which binds to the elongation factor 2 and blocks protein synthesis, can sp
22 ation but increases the association of human elongation factor 2 and human heterogeneous nuclear ribo
23 catalyzed the ADP-ribosylation of eukaryotic elongation factor 2 and inhibited protein synthesis.
24 ates to the cytosol where it ADP-ribosylates elongation factor 2 and inhibits protein synthesis.
25 ranslation by stimulating GTPase activity of elongation factor-2 and removal of deacylated tRNA.
26  the presence of the translocase, eukaryotic elongation factor 2, and guanosine 5'-triphosphate hydro
27 tes and inactivates eukaryotic translational elongation factor-2, and thus can modulate the rate of p
28 osomal protein S4, malate dehydrogenase, and elongation factor 2, as well as two novel parasite prote
29 tep in the posttranslational modification of elongation factor-2 at His(715) that yields diphthamide,
30 4 resulted in increased dephosphorylation of elongation factor 2, but had no effect on phosphorylatio
31 kills by ADP-ribosylation of the translation elongation factor 2, but many of the host factors requir
32          Archaeal and eukaryotic translation elongation factor 2 contain a unique post-translationall
33 (P < 0.05) and phosphorylation of eukaryotic elongation factor 2 decreased (P < 0.05) after exercise
34 esent on archaeal and eukaryotic translation elongation factor 2, diphthamide represents one of the m
35 regions of endogenous eukaryotic translation elongation factor 2 (eEF-2) gene] using the Clustered Re
36 y increase the phosphorylation of eukaryotic elongation factor 2 (eEF-2) in extracts of NIH3T3 cells.
37 demonstrated that the activity of eukaryotic elongation factor 2 (eEF-2) kinase was markedly increase
38 ibosome association of the GTPase eukaryotic elongation factor 2 (eEF-2) resulting from its specific
39 by phosphorylating its substrate, eukaryotic elongation factor 2 (eEF-2), thereby reducing its affini
40 ion of the diphthamide residue of eukaryotic elongation factor 2 (eEF-2).
41  of the guanosine triphosphatase, eukaryotic elongation factor 2 (eEF-2).
42 thesis through phosphorylation of eukaryotic elongation factor 2 (eEF-2).
43 ulin-dependent phosphorylation of eukaryotic elongation factor-2 (eEF-2) by eukaryotic elongation fac
44 d autophagy, whereas silencing of eukaryotic elongation factor-2 (eEF-2) kinase, a protein synthesis
45  induced the phosphorylation of a eukaryotic elongation factor-2 (eEF-2) kinase, radiation sensitivit
46 eased level of phosphorylation of eukaryotic elongation factor-2 (eEF-2) was observed in the brains a
47 at phosphorylates and inactivates eukaryotic elongation factor 2 (eEF2 kinase; eEF2K) is subject to m
48 in 1 (4EBP1 Thr37/46; 14 +/- 3%), eukaryotic elongation factor 2 (eEF2 Thr56; -47 +/- 4%), extracellu
49        Furthermore, we found that eukaryotic elongation factor 2 (eEF2) and its kinase eEF2K are key
50 ture cortical neurons express the eukaryotic elongation factor 2 (eEF2) at lower levels than other ce
51 trimethylation on the eukaryotic translation elongation factor 2 (EEF2) at Lys525.
52                            Protein synthesis elongation factor 2 (eEF2) catalyzes the translocation o
53 osphatase calcineurin and promote eukaryotic elongation factor 2 (eEF2) dephosphorylation, increasing
54                       Eukaryotic translation elongation factor 2 (eEF2) facilitates the movement of t
55 an target of rapamycin (mTOR) and eukaryotic elongation factor 2 (eEF2) in the mPFC, effects recently
56                       Eukaryotic translation elongation factor 2 (eEF2) is a key regulatory factor in
57                 Translocation of the IRES by elongation factor 2 (eEF2) is required to bring the firs
58  diphthamide on human eukaryotic translation elongation factor 2 (eEF2) is the target of ADP ribosyla
59 kade of NMDAR at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase (also called CaMKIII),
60  mammalian starvation response is eukaryotic elongation factor 2 (eEF2) kinase (eEF2K), which suppres
61 roteasome-targeted degradation of eukaryotic elongation factor 2 (eEF2) kinase and activation of the
62 MDA receptors at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase, resulting in reduced
63  an inhibitory phosphorylation of eukaryotic elongation factor 2 (eEF2) kinase, which in turn promote
64                                   Eukaryotic elongation factor 2 (eEF2) mediates translocation in pro
65 A catalyzes the trimethylation of eukaryotic elongation factor 2 (eEF2) on Lys-525.
66  elongation is phosphorylation of eukaryotic elongation factor 2 (eEF2) on threonine 56 (T56) by eEF2
67                      In addition, eukaryotic elongation factor 2 (eEF2) phosphorylation was significa
68 on inhibition through eukaryotic translation elongation factor 2 (eEF2) phosphorylation, which in tur
69      Mechanistically, EXOA-driven eukaryotic elongation factor 2 (EEF2) ribosylation and covalent ina
70 mpairs the ability of eukaryotic translation elongation factor 2 (eEF2) to bind to the ribosome via T
71 through inhibition of eukaryotic translation elongation factor 2 (eEF2) via adenosine diphosphate (AD
72 ssociated hyperphosphorylation of eukaryotic elongation factor 2 (eEF2) was blunted with selective AM
73 ing protein (Tbp) and eukaryotic translation elongation factor 2 (Eef2) were not affected by inflamma
74 is in a mouse liver by targeting translation elongation factor 2 (eEF2) with RNAi.
75 increasing the phosphorylation of eukaryotic elongation factor 2 (eEF2), a key component of the trans
76 ne residue unique for eukaryotic translation elongation factor 2 (eEF2), a key ribosomal protein.
77                   The eukaryotic translation elongation factor 2 (eEF2), a member of the G-protein su
78 also increased phosphorylation of eukaryotic elongation factor 2 (eEF2), a process known to inhibit p
79 and found that phosphorylation of eukaryotic elongation factor 2 (eEF2), a ribosomal translocase whos
80   In the periphery, OXT activates eukaryotic elongation factor 2 (eEF2), an essential mediator of pro
81 ion (inactivation) of eukaryotic translation elongation factor 2 (eEF2), an important molecule for pr
82 6k), ribosomal protein S6 (rpS6), eukaryotic elongation factor 2 (eEF2), and eukaryotic initiation fa
83 es the involvement of eukaryotic translation elongation factor 2 (eEF2), the phosphorylation of which
84 f the diphthamide modification on eukaryotic elongation factor 2 (eEF2), we generated an eEF2 Gly(717
85    In eukaryotes translocation is ensured by elongation factor 2 (eEF2), which catalyses the process
86 n this study, we demonstrate that eukaryotic elongation factor 2 (eEF2), which catalyzes the GTP-depe
87  controlled by phosphorylation of eukaryotic elongation factor 2 (eEF2), which inhibits its activity
88 ar target has been identified as translation elongation factor 2 (eEF2), which is responsible for the
89 lation of mRNA translation factor eukaryotic elongation factor 2 (eEF2), which results in inhibition
90  a simultaneous inhibition of the eukaryotic elongation factor 2 (eEF2), which results in tumor suppr
91 esis by impairing the function of eukaryotic elongation factor 2 (eEF2).
92 e now identify as the eukaryotic translation elongation factor 2 (eEF2).
93 the translocation intermediate stabilized by elongation factor 2 (eEF2).
94 ein kinase and phosphorylation of eukaryotic elongation factor 2 (eEF2).
95 osphorylation and inactivation of eukaryotic elongation factor 2 (eEF2).
96 receptor-dependent suppression of eukaryotic elongation factor-2 (eEF2) phosphorylation thus reversin
97                 Here, we identify eukaryotic elongation factor-2 (eEF2), which catalyzes ribosomal tr
98 protein synthesis, which specifically impair elongation factor 2 (EF-2) function.
99 longation factor G (EF-G) in prokaryotes and elongation factor 2 (EF-2) in eukaryotes].
100                                              Elongation factor 2 (EF-2) plays a key role in the essen
101 ffects did not stem from ADP-ribosylation of elongation factor 2 (EF-2).
102 the endothelium, promotes phosphorylation of elongation factor-2 (EF-2) and prostacyclin production,
103                                              Elongation factor-2 (EF-2) kinase (calmodulin kinase III
104  DT transfers the ADP-ribose group of NAD to elongation factor-2 (EF-2), rendering EF-2 inactive.
105 (4) genes responsible for protein synthesis (elongation factor-2 [EF-2], eukaryotic initiation factor
106 osttranslational modification on translation elongation factor 2 (EF2) in archaea and eukaryotes.
107                                              Elongation factor 2 (EF2) is an essential protein cataly
108                                              Elongation factor 2 (EF2) is phosphorylated and inhibite
109 ), beta actin (ACTB), eukaryotic translation elongation factor 2 (EF2), glyceraldehyde-3-phosphate de
110 hibitor Exotoxin A (ToxA), which ribosylates elongation factor 2 (EF2), upregulates a significant sub
111 de, a modification found only on translation elongation factor 2 (EF2), was proposed to suppress -1 f
112  large subunit ribosomal DNA and translation elongation factor 2 (EF2).
113 ication in archaeal and eukaryal translation elongation factor 2 (EF2).
114 ation on eukaryotic and archaeal translation elongation factor 2 (EF2).
115 2 is unable to ADP ribosylate and inactivate elongation factor-2 (EF2), owing to a low level of DPH4
116 g cells by ADP-ribosylating and inactivating elongation factor-2 (EF2).
117 thetase, glutaminyl-transfer RNA synthetase, elongation factor 2, elongation factor 1delta, and eukar
118              The PCR was used to amplify the elongation factor 2 gene in both the tumor cells and the
119 ng vimentin, EH-domain-containing protein 2, elongation factor 2, glucose-regulated protein 78, trans
120 ene product, ribosomal protein S6, cyclin K, elongation factor-2, Grb2-associated protein 2, and othe
121                              The translation elongation factor 2 in eukaryotes (eEF-2) contains a uni
122 m nicotinamide adenine dinucleotide (NAD) to elongation factor-2 in eukaryotic cells, inhibiting prot
123 abamiquine, a Plasmodium-specific eukaryotic elongation factor 2 inhibitor, to select for resistant P
124        Calmodulin (CaM)-dependent eukaryotic elongation factor 2 kinase (eEF-2K) impedes protein synt
125                  The alpha-kinase eukaryotic elongation factor 2 kinase (eEF-2K) regulates translatio
126                  The alpha-kinase eukaryotic elongation factor 2 kinase (eEF-2K), a key regulator of
127                                   Eukaryotic elongation factor 2 kinase (eEF-2K), a member of the alp
128                                   Eukaryotic elongation factor 2 kinase (eEF-2K), an atypical calmodu
129 almodulin-activated alpha-kinase, eukaryotic elongation factor 2 kinase (eEF-2K), serves as a master
130                                   Eukaryotic elongation factor 2 kinase (eEF-2K), the only calmodulin
131                      We also used eukaryotic elongation factor 2 kinase (eEF2K) (also known as CaMKII
132 plitudes by reducing postsynaptic eukaryotic elongation factor 2 kinase (eEF2K) activity subsequent t
133                                   Eukaryotic elongation factor 2 kinase (eEF2k) impairs the ability o
134                                   Eukaryotic elongation factor 2 kinase (eEF2K) is a Ca(2+)/calmoduli
135                                   Eukaryotic elongation factor 2 kinase (eEF2K) is a stress-responsiv
136                                   Eukaryotic elongation factor 2 kinase (eEF2K) is the best-character
137                                   Eukaryotic elongation factor 2 kinase (eEF2K) negatively regulates
138                                              Elongation factor 2 kinase (eEF2k) phosphorylates and in
139       These findings also uncover eukaryotic elongation factor 2 kinase (eEF2K), a Ca(2)(+)/calmoduli
140                                   Eukaryotic Elongation Factor 2 Kinase (eEF2K), a member of the alph
141                                   Eukaryotic elongation factor 2 kinase (eEF2K), an atypical calmodul
142                    Here, we demonstrate that elongation factor 2 kinase (eEF2K), an evolutionarily co
143 protein synthesis by inactivating eukaryotic elongation factor 2 kinase (eEF2K), which, when active,
144 It was purified and identified as eukaryotic elongation factor 2 kinase (eEF2K).
145 ptide chain elongation through activation of elongation factor 2 kinase (eEF2K).
146 ch is controlled by the Ca(2+)/CaM-dependent elongation factor 2 kinase (eEF2K).
147 LPA regulates KLF5 expression via eukaryotic elongation factor 2 kinase (eEF2k).
148 d higher levels of phosphorylated eukaryotic elongation factor 2 kinase than were observed in Mtm1 p.
149 des the activation of eukaryotic translation elongation factor 2 kinase with a consequent inhibition
150 ering RNA (siRNA) to eEF2 kinase (eukaryotic elongation factor 2 kinase) blocked the dendritic MAP1B
151 ivation and downregulation of the eukaryotic elongation factor 2 kinase, which normally inhibits tran
152 n factor 2 and also requires the presence of elongation factor 2 kinase.
153 , rat, and Caenorhabditis elegans eukaryotic elongation factor-2 kinase (eEF-2 kinase) and found that
154                                   Eukaryotic elongation factor-2 kinase (eEF-2 kinase) is a highly co
155 gy by 2-DG was associated with activation of elongation factor-2 kinase (eEF-2 kinase), a structurall
156                                              Elongation factor-2 kinase (eEF-2 kinase), also known as
157                                              Elongation factor-2 kinase (eEF-2K) is a Ca(2+)/calmodul
158                                   Eukaryotic elongation factor-2 kinase (eEF-2K), a member of the alp
159               We report here that eukaryotic elongation factor-2 kinase (eEF-2K), a negative regulato
160 inase inhibitors against a mammalian enzyme, elongation factor-2 kinase (eEF-2K), and the effect of t
161                                   Eukaryotic elongation factor-2 kinase (eEF2K) relays growth and str
162 ic elongation factor-2 (eEF-2) by eukaryotic elongation factor-2 kinase (EF2K), which inhibits elonga
163  required protein translation and eukaryotic elongation factor-2 kinase activity.
164 -2 kinase and a putative nematode eukaryotic elongation factor-2 kinase also encode the catalytic dom
165 gments of homology present in rat eukaryotic elongation factor-2 kinase and a putative nematode eukar
166 d neurotrophic factor expression, eukaryotic elongation factor-2 kinase function, and increased surfa
167               This class includes eukaryotic elongation factor-2 kinase, Dictyostelium myosin heavy c
168 r endothelial cells by activating eukaryotic elongation factor-2 kinase.
169          The LOS1 gene encodes a translation elongation factor 2-like protein.
170 ot inhibit the phosphorylation of eukaryotic elongation factor 2 or augment subsequent expression of
171 chanism of action, inhibition of translation elongation factor 2 (PfEF2), led to progression of 2 (DD
172 city through ADP-ribosylation of translation elongation factor 2, predicated on binding to specific c
173 exogenous substrate (yeast protein synthesis elongation factor 2), primarily on Ser.
174 P dissociation inhibitor beta, ATP synthase, elongation factor 2, protein disulfide isomerase, nucleo
175     These genes have been designated EFR for Elongation Factor 2 Related.
176  modification of histidine 715 in eukaryotic elongation factor 2, resulted in tagraxofusp resistance.
177                         Finally, analyses of elongation factor 2 sequences demonstrate a strong phylo
178 RNA reporter constructs with the 5'-TOP from elongation factor 2 showed decreased translational activ
179  cytosolic ribosomes, as well as translation elongation factors; (2) slows down translation elongatio
180 osttranslational modification of translation elongation factor 2 that is conserved in all eukaryotes
181 d to interfere with binding of the substrate elongation factor 2 to the enzymatic active site of the
182 itor that impairs the function of eukaryotic elongation factor 2, whereas the rpl40a and rpl40b null

 
Page Top